---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-010449"
form_type: "8-K"
ticker: "CAPR"
cik: "0001133869"
company_name: "CAPRICOR THERAPEUTICS, INC."
filed_at: "2022-06-29T23:59:59+00:00"
generated_at: "2026-06-24T22:17:04.298865+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "low"
source: SEC EDGAR
---

# Capricor provides top-line update from HOPE-2 open label extension trial

## Summary
- Capricor reported top-line results from HOPE-2 OLE (1-year data) via slide presentation on June 27, 2022.
- The slide presentation was made available on the company's website; specific data not detailed in the filing.
- No numerical results or endpoint data are included in the filed exhibit; only a title slide is reproduced.
- The update was disclosed under Regulation FD; a conference call was held the same day.

## SEC filing metadata
- accession: 0001558370-22-010449
- form_type: 8-K
- ticker: CAPR
- cik: 0001133869
- company_name: CAPRICOR THERAPEUTICS, INC.
- filed_at: 2022-06-29T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1133869/000155837022010449/0001558370-22-010449-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1133869/000155837022010449/capr-20220627x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-010449
- JSON: https://secwatch.observer/filing/0001558370-22-010449.json
- Plain text: https://secwatch.observer/filing/0001558370-22-010449.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.